Comparison of the effect of Erythropoietin, L-Carnitine and Erythropoietin plus L-Carnitine in correction of anemia in chronic haemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN96315193

Enrollment

Registered

2005-08-11

Start date

2003-03-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Renal Failure (End-Stage Renal Disease [ESRD]) Urological and Genital Diseases Renal failure

Interventions

1. Administration of rHu-EPO 4000 IU/week, subcutaneously (SC) (2000 IU, twice weekly) for 3 months (N = 20) 2. Administration of L-Carnitine 500 mg/day, orally, for 3 months (N = 15) 3. Administratio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Dialysis for more than 6 months 2. Hb less than 11 g/dl

Exclusion criteria

Exclusion criteria: 1. Active infectious disease 2. Active bleeding disorders

Design outcomes

Primary

Measure	Time frame
Haemoglobin level	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

Iran

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026